# CCB Capital

> CCB Capital is a VC fund in Beijing backing Health Care, Manufacturing and Biotechnology. See 16 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Beijing, China
- Total investments: 16
- Last investment: Jun 2023
- Lead investor: 13%
- Last updated: Aug 2026
- Website: https://www.ccbcapital.cn/

CCB Capital is an asset management company.

## Round sizes

| Stage | Round size |
| --- | --- |
| Series A | $1.4M–$18M |
| Series B | $89M–$278M |
| Series C | $4.1M–$116M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 4 | 25% |
| Manufacturing | 4 | 25% |
| Biotechnology | 3 | 19% |
| Pharmaceutical | 3 | 19% |
| Battery | 2 | 13% |

33 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 8 | 50% |
| Series C | 4 | 25% |
| Series A | 2 | 13% |
| Series E | 1 | 6% |
| Venture - Series Unknown | 1 | 6% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| China | 14 | 88% |
| Hong Kong | 1 | 6% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Sunwoda Electric Vehicle Battery | Sunwoda Electric Vehicle Batter provides electric vehicle battery pack solutions for new energy vehicle companies through advanced lithium battery integration technology. | $229.8M | Series B | Jun 25, 2023 |  |
| Cygnus Biosciences | Cygnus Biosciences (Beijing) Co., Ltd. is a high-tech company specializing in R & D and industrialization of gene sequencing platform and committed to clinical medicine screening and diagnosis. |  | Series C | Mar 20, 2023 |  |
| China Resources Pharmaceutical Group | China Resources Pharmaceutical Group operates as a pharmaceutical company. The Company researches, develops, manufactures, and distributes Chinese, western, and other medicines and health foods. China Resources Pharmaceutical serves customers throughout China. | $88.5M | Series B | Jan 10, 2023 |  |
| CanSemi | CanSemi is a chip manufacturing plant that manufactures microprocessors, power management chips, analog chips, and power discrete devices. |  | Series B | Nov 29, 2022 |  |
| Hithium Energy Storage | Hithium is a tech enterprise, specializing in the R&D, production, and sales of lithium-ion battery core materials, LFP energy storage batteries, and systems. | $277.7M | Series B | Oct 18, 2022 |  |
| YUSUR Technology | YUSUR Technology is a Chinese startup on data processing units |  | Series B | Sep 19, 2022 |  |
| Meike Solar | Meike Solar focuses on the research and development of solar photovoltaic polycrystalline silicon wafers and operates integrated monitoring systems and equipment to facilitate intelligent manufacturing processes, permitting itself to make products efficiently at a reduced cost. | $188.3M | Series B | Dec 21, 2021 |  |
| Chipone Technology | Chipone North is a chip design company focusing on the display field, and it is also one of the few domestic display chip design companies with global competitiveness. The company’s products cover TDDI (display driver and touch integrated chip), medium and large size display driver chip (LDDI), OLED display chip, power management chip, LED displaydriver chip, timing control chip (Tcon), fingerprint recognition chip, touch A full range of display chips such as control chips and silicon-based OLED chips. The customer base covers mainstream global panel manufacturers, domestic first-line mobile phone terminal brand customers and well-known LED display manufacturers. | $1B | Series E | Dec 15, 2021 |  |
| North Ocean Photonics | North Ocean Photonics is a Smart Hardware Company. |  | Series B | Nov 22, 2021 |  |
| Xiaoyu Yilian | Xiaoyu Link is an online video conference solution provider. Xiaoyu Link plans to use the proceeds to enhance its sales and marketing efforts, as well as carrying out research in new products and technologies. |  | Venture - Series Unknown | Nov 02, 2021 |  |

10 of 16 investments shown.

## Co-investors
- [Shenzhen Capital Group](https://shizune.co/investors/profile/shenzhen-capital-group) — VC Fund, 3 deals together
- [ABC International](https://shizune.co/investors/profile/abc-international) — VC Fund, 2 deals together
- [GGV Capital](https://shizune.co/investors/profile/ggv-capital) — VC Fund, 2 deals together
- [IDG Capital](https://shizune.co/investors/profile/idg-capital-partners) — VC Fund, 2 deals together
- [Source Code Capital](https://shizune.co/investors/profile/source-code-capital) — VC Fund, 2 deals together
- [Alibaba Health Information Technology](https://shizune.co/investors/profile/alibaba-health-information-technology) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [Praxis](https://shizune.co/investors/profile/praxis-2) — VC Fund
- [New Media Ventures](https://shizune.co/investors/profile/new-media-ventures) — VC Fund
- [Social and Sustainable Capital](https://shizune.co/investors/profile/social-and-sustainable-capital) — VC Fund

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

### Similar country
- [IDG Capital](https://shizune.co/investors/profile/idg-capital-partners) — VC Fund
- [Qiming Venture Partners](https://shizune.co/investors/profile/qiming-venture-partners) — VC Fund
- [HSG](https://shizune.co/investors/profile/sequoia-capital-china) — VC Fund

## Featured in investor lists
- [Non Profit Investors in China](https://shizune.co/investors/non-profit-investors-china)
- [Non Profit VC Funds in China](https://shizune.co/investors/non-profit-vc-funds-china)

## FAQ

### What does CCB Capital invest in?

CCB Capital invests primarily in Health Care, Manufacturing and Biotechnology startups, most often at Series B and Series C stage. Most of the 16 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is CCB Capital's check size?

CCB Capital typically joins rounds of $1.4M–$18M at Series A, $89M–$278M at Series B and $4.1M–$116M at Series C. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds CCB Capital participates in.

### When did CCB Capital last invest?

The most recent investment recorded for CCB Capital closed in Jun 2023. Shizune tracks 16 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co